Lenstec, Inc.
Lenstec, Inc. is a Florida-based medical device corporation serving the global ophthalmic surgical market, with products currently marketed in more than 60 countries. We design, manufacture and distribute a wide range of intraocular lens (IOL) implants and lens injection systems, and have an established reputation for rapid prototype design and development and high quality/low cost manufacturing. In late April 2010, Lenstec received its first US FDA approval with the Softec HD bi-aspheric lens. This lens is the first monofocal implant to be approved with 0.25D steps and is designed to be the most accurate IOL on the market today. It is a hydrophilic acrylic implant made from a hydrogel base material that is currently used by many other internationally known IOL companies worldwide.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
- Year Founded:
- 1993
- Employees:
- 101-1000
About Us
In June 2010, Lenstec received its second US FDA approval with the Softec I implant. The Softec I is a traditional “non-aspheric” optic design with traditional 0.5D steps and in the same material and Mod-C loop design. It is a lens that provides a new technology material to the traditional IOL for a strong upgrade from low cost silicone implants for the cost-conscious ASC facility.
Founded in 1993, Lenstec currently has offices in Florida and the United Kingdom, and a 30,000 sq. ft. manufacturing facility in Barbados, designed by Lenstec to exceed all medical device standards.
Lenstec Supports Cambodian Missions
Lenstec have supported the Khmer Sight Foundation for a number of years in their mission to eliminate avoidable blindness and provide expert clinical training to eye care health professionals in Cambodia. Their mission is to become self-reliant in the provision of high quality, safe and effective eye care.
Lenstec Continues Going Green!
We recently installed solar panels on our manufacturing facility in Barbados. This system enables us to manufacture IOL's using clean solar electricity, helping us to combat greenhouse gas emissions and reduce our collective dependence on fossil fuels.
This is combined with Lenstec UK's move to 100% recyclable packaging materials are just a few of the changes we have made in 2021 for a more sustainable future.
Company History
- Founded in 1993 as technology transfer company
- Built 8 IOL laboratories around the world
- Currently more IOLs are made with Lenstec technology worldwide than any other system
- Started Lenstec Barbados in 1995
- Currently have supplied more than 7,000,000 lenses worldwide
Lenstec currently produces lenses for several IOL companies under private label.
Our proprietary lens manufacturing technologies enable the company to produce premium lenses with reduced variability which can improve surgical predictability. In addition, most of the micro-precision lathes, mills, polishing equipment, molds, processing equipment and processes are designed and built in-house by Lenstec’s engineering staff.
At Lenstec we continuously strive to improve vision possibilities through research, testing and partnerships with the world’s leading ophthalmologists. We welcome your interest in the company and any questions you may have about our products and services or opportunities to partner with us.
Manufacturing
Lenstec opened its first manufacturing facility in Barbados in 1995. In 2009, after two years of planning and building, the new manufacturing space opened which at 30,000 square feet is double the size of the previous facility and has the growth capacity to meet expected market demand for the next decade.
Following the move into the new facility and successful completion of environmental and production validations, the factory was certified by British Standards Institute, ensuring a seamless supply of Lenstec products to customers. Lenstec first received the CE Mark in 1997.
As a global manufacturer of intraocular lenses for cataract and refractive surgery, Lenstec’s Barbados-based manufacturing operation currently produces in excess of 300,000 IOLs and other ophthalmic devices per year. Lenstec currently employs over 200 people in Barbados.